glp-1 parkinson's disease drug may help with disease, study reports GLP-1 Agonists: A New Frontier

Results showed that subcutaneous exenatide increased postprandial EF independently of glucose and triglyceride reductions

DISCLAIMER The information provided on Care Access is intended for informational purposes only and should not be considered as a substitute for professional medical advice, diagnosis, or treatment

Over half the global population is ruled by non-centrist types of government, including autocracies and left or right wing parties

It is vital that you only purchase your medication from a Registered Healthcare Professional with a valid Prescribing ID that can be verified by a professional body such as GPhC, GMC or NMC.

Feb 27, 2026 Before you increase your semaglutide dose, there is something your prescriber probably has not mentioned